INTRODUCTION
Inflammation is a major secondary pathophysiological factor after stroke [1, 2] . The local cerebral inflammation is involved in focal brain edema, hemorrhage, and tissue necrosis.
These events are associated with further impairment of neurological outcome. Moreover, recent studies described the phenomenon of the so called CNS injury-induced immunodepression (CIDS), which is a result of a systemic reduction of circulating lymphocytes and impaired T-and natural killer cell activity, and frequently leads to severe systemic infections with an increase in mortality [3, 4] . Systemic infections are important in the context of stroke. On the one hand, it is well known that preceding infections are a significant risk factor for cerebral infarction [5] . On the other hand, it was shown that stroke-associated infections (SAI) are a predictor of a poor functional outcome [6] . However, the fact that SAI are not independently associated with the neurological outcome after stroke suggests that they do not contribute to cerebral damage, but are a simple marker of stroke severity [6] .
This fact is reflected in great clinical trials showing the inefficacy of antibiotic prophylaxis to improve neurological outcome after stroke [7] .
Under normal conditions the immune system, particularly T cells, are anergic to cerebral antigens. Following stroke, cerebral inflammation may lead to an autoimmune response directed against neuroepitopes, which can in turn result in further brain injury. Supporting this hypothesis, recent studies showed that administration of lipopolysaccharide (LPS) in a rat model of stroke induced a Th1 immune response toward myelin basic protein (MBP) resulting in persisting severe postischemic brain injury [8] . On the other hand, induction of tolerance by nasal vaccination to MBP or myelin oligodendrocyte glycoprotein led to reduction of infarct size and neurological improvement [9, 10] . Thus, antigenpresenting cells may play a crucial role for the neurological damage after stroke. A c c e p t e d M a n u s c r i p t Licenced copy. Copying is not permitted, except with prior permission and as allowed by law.
mune response against antigen which were so far not recognized by the immune system [11] . Thus, DC might be the best candidates for the supposed primary immune response against neuroepitopes after stroke. Two lineages of DC can be differentiated: Myeloid DC which respond to bacteria and fungi, releasing IL-12, as well as plasmacytoid DC which release interferon-α upon viral infection [12] . Both lineages can be detected as DC precursors (DCP) in blood, patrolling through the circulation, invading the tissue in response to a local infection or other inflammatory situation. After migration into the tissue, as immature DC they are enabled to take up antigens, and upon subsequent maturation acquire the ability to stimulate T cells against those antigens (mature DC). In recent times, the role of myeloid (mDC) or plasmacytoid (pDC) has been implicated in several pro-inflammatory diseases, e.g. atherosclerosis [13, 14] . Furthermore, in multiple sclerosis it was shown that mDC invade the human brain, subsequently triggering cerebral inflammation [15] .
The aim of the present study was to investigate if circulating DCP are transiently reduced in patients with acute cerebral ischemia due to their recruitment into the infarcted brain, and if there is evidence for a DC-triggered cerebral (auto)immune response. A c c e p t e d M a n u s c r i p t Licenced copy. Copying is not permitted, except with prior permission and as allowed by law. rhage) were analyzed in the CT scan by a radiologist, and their maximum diameter was assessed. According to the maximum diameter, acute cerebral ischemia were radiologically classified as (1) small stroke (<10 mm), (2) medium stroke (10-30 mm), and (3) large stroke (>30 mm). Furthermore, the etiology of stroke was classified according to the Trial of Org 10172 in Acute Stroke Treatment (TOAST) criteria [16] . The clinical severity of the stroke was evaluated at admission according to the National Institute of Health Stroke Scale (NIHSS) [17] . Patients with AIS admitted within 3 hours after onset of symptoms and 4 to 22 points according to NIHSS underwent rt-PA thrombolysis according to the National Institute of Neurological Disorders and Stroke criteria and AHA guidelines (n=18).
MATERIALS AND METHODS

Patients and controls
Between
The control group consisted of 29 sex-and age-matched cerebrovascular healthy subjects who presented themselves for a healthy checkup. Additionally, 46 patients were analyzed with significant ACI stenosis (> 70%) but without acute cerebral ischemia which were planned for routine carotid endarterectomy. Exclusion criteria were acute or chronic infections, malignancies, autoimmune diseases, hyperthyroidism, acute coronary syndromes, and immunosuppressive medication. Routine blood analyses were performed according to clinic standard. Standardized blood sampling for flow cytometrical analysis was carried out in the first hours after admission and in case of an acute cerebral ischemia at follow-up after 2 days (TIA) or 4 days (stroke). Immediately after blood withdrawal, samples were flow cytometrically analyzed. Informed consent was obtained from all patients. The study was approved by institutional ethics committee of the University Hospital Erlangen.
Serum analysis of pro-inflammatory markers
Serum concentration of high-sensitivity CRP (hsCRP) was measured using an immu- 
Identification of DC precursors by Fluorescence Activated Cell Sorting (FACS)
Fresh blood samples collected on EDTA were analyzed using the Blood Dendritic Cell Enumeration kit TM (Miltenyi Biotec, Bergisch Gladbach, Germany). Three color-staining and FACS analysis were performed as previously described [18] . FACS analysis was performed using the FACSCalibur flow cytometer with CellQuest software (Becton Dickinson). Since circulating DCP comprise only 0.1 to 1% of white blood cells (WBC), a special gating strategy ( Figure 1 ) was used to analyze mDCP, pDCP, and tDCP accurately, as described [18] . The relative cell numbers of circulating DCP were assessed as a percentage of WBC (% WBC). The absolute cell numbers (cells/µL) were calculated using relative cell numbers multiplied by white blood cell count.
Histological characterization of infarcted brain after stroke
Serial slides of brain tissue of patients deceased after stroke and control slides were kindly provided from Prof. I. Blümcke (Neuropathology, University Hospital Erlangen). Brain morphology was analyzed by an experienced neuropathologist using haematoxylin/eosin staining. No major autolytic changes have been observed after a thorough microcopical inspection. Minor changes were present in all specimens and included an increased extracellular space. Subsequently, specimens were classified as acute ischemic (n=17), acute hemorrhagic (n=12), or past stroke (PS > 4 weeks, n=12), and healthy tissue (n=11).
Immunohistochemical detection of DC and T cells in infarcted human brain
For immunohistochemical staining, the following monoclonal antibodies were used: anti- 
Statistical analysis
All values are reported as median. P < 0.05 was considered statistically significant. Clinical data (Table 1) were statistically compared between patients and controls by one-way ANOVA test. The correlation of mDCP, pDCP, and tDCP with different parameters was analyzed by the non-parametric Spearman Rank Order test (Table 2) . Unless stated otherwise, all other comparisons and statistical analyses were done using the non-parametric
Mann-Whitney Rank Sum test.
RESULTS
Baseline characteristics
The baseline characteristics are reported in Table 1 . No significant differences were observed for age, gender, medical history, atherogenic risk factors, and current medication.
Most of the serum parameters did not differ between the study groups. Patients with acute cerebral ischemia had a trend for higher serum glucose. Regarding inflammation, significantly higher levels of leukocytes and hsCRP were detected in patients with AIS and AHS than controls (Table 1 ). According to TOAST criteria the cause of stroke was large-artery A c c e p t e d M a n u s c r i p t
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atherosclerosis in 20%, cardioembolism in 25%, small-artery occlusion in 23%, other determined etiology in 2%, and undetermined etiology in 30%.
Decrease in circulating DCP in patients with acute ischemic and hemorrhagic stroke
Compared to healthy controls, in patients with TIA, AIS, and AHS a significant decrease in relative and absolute levels of circulating mDCP and tDCP was observed ( Figure 2 ).
Regarding pDCP, a statistical significant reduction of their relative and absolute levels was observed in patients with AIS and AHS, whereas in patients with TIA, the values were slightly lower than in controls. Since both the relative and, more importantly, the absolute values of circulating DCP were reduced, we were able to exclude that their decrease might be caused by a secondary dilution phenomenon due to an increase in another WBC population. In follow-up analysis of patients with acute cerebral ischemia, a significant reconstitution of circulating DCP was observed after 2 days (TIA) or 4 days (AIS, AHS), suggesting that their reduction is a transient phenomenon in stroke (data not shown). In contrast, patients with asymptomatic ACI stenosis did not show any significant alterations of circulating DCP compared to the healthy controls ( Figure 2 ).
Subgroup/correlation analysis of circulating DCP regarding various clinical factors
Regarding TOAST criteria, the decrease in circulating DCP in patients with acute cerebral ischemia was independent of their etiology (data not shown). In healthy controls, the values of circulating DCP did not differ significantly between the sexes. In contrast, females with acute cerebral ischemia had significantly lower mDCP (9.4 vs. A c c e p t e d M a n u s c r i p t
cantly higher values of circulating mDCP and tDCP. Moreover, circulating pDCP were significantly elevated in patients under AT1-antagonist treatment.
To analyze whether the decrease in circulating DCP might be directly associated with other clinical factors, correlation analysis was performed ( Table 2 ). The age of the patients inversely correlated with circulating DCP. Regarding the clinical severity of stroke, a significant inverse correlation was observed between all subtypes of circulating DCP and the NIHSS (Table 2, Figure 3) . A significant inverse correlation between circulating DCP and leukocytes or hsCRP was observed (Table 2, Figure 3 ). Blood glucose or HbA1c levels were significantly inversely correlated with circulating DCP (Table 2 ).
Additionally we investigated whether the decrease in circulating DCP might be associated with the radiologically evaluated stroke size ( Figure 4 ). For this reason, patients with ischemic and hemorrhagic stroke were subdivided according to the CT scan into three subgroups with small, medium, and large infarction diameter. In concordance with the results for the NIHSS, we observed significantly lower values of circulating mDCP, pDCP, and tDCP in patients with larger stroke. Separate analysis of patients with ischemic and hemorrhagic stroke provided the same results but without statistical significance due to the limited number of patients in the divided groups (data not shown). Altogether, these results suggest that the reduction of DCP in stroke can be caused by their rapid recruitment from blood into the infarcted brain.
Emergence of mDC colocalized with T cells in the infarcted brain
To investigate whether circulating DCP are recruited into the infarcted brain, we analyzed human autopsy samples for the presence of DC and T cells, and their immunostimulatory capacity. Compared to control tissue, in the area affected by acute ischemic or hemorrhagic stroke numerous mDC and T cells, and to a lower extent pDC, were observed ( Figure 5A ).
Regarding the cell distribution, mDC and T cells were often located around intracerebral 
DISCUSSION
Recent studies revealed that immunological mechanisms play an important role for the neurological and overall outcome after stroke. The breakdown of blood brain barrier contributes to an invasion of immune cells into the infarcted brain after stroke. These cells upon encountering novel brain antigens, initiate an autoimmune response which leads to further destruction of neurological tissue [19] . On the other hand, a systemic immunodepression syndrome emerging after stroke is the reason for frequent systemic infections [3, 4] . The aim of our present study was to investigate if local and systemic alterations of DC contribute to the local immune response, or to the systemic immunodepression after stroke.
In our present study, we show that circulating myeloid, plasmacytoid, and total DCP are significantly reduced in patients with TIA, acute ischemic, or hemorrhagic stroke. A c c e p t e d M a n u s c r i p t
not a specific pre-existing situation, but rather the common consequences of stroke, that lead to the decrease in circulating DCP. In short-term follow-up analysis, a rapid recovery of circulating DCP was observed, suggesting that their transient decrease might be a result of an enhanced emigration from blood into the infarcted brain. Supporting this hypothesis, it is known from other inflammatory diseases that a decrease in circulating DCP is mostly caused by their recruitment into areas of inflammation [20] .
Unexpectedly, no significant changes in the levels of circulating DCP were observed in patients with asymptomatic ACI stenosis compared to controls, although it is known that circulating DCP emigrate into atherosclerotic lesions [13, 21] . In contrast, in patients with stable coronary artery disease a significant decrease in circulating DCP was described which is dependent of the extent of coronary atherosclerotic burden [22] . However, limited number of patients in the ACI stenosis group may be the reason that we were unable to detect any alterations.
Regarding inflammation, a strong inverse correlation was found between circulating DCP and hsCRP. This is not surprising, since it is known that CRP is able to directly induce an upregulation of adhesion molecules on endothelial cells [23] , as well as to induce the release of the chemokines CCL2, CCL3, and CCL4 from monocytes [24] . Thus, elevated CRP levels are probably a major contributing factor for the emigration of circulating DCP to the sites of inflammation.
As it is possible that the transient decrease in circulating DCP in acute cerebral ischemia is caused by their rapid recruitment into the infarcted brain, human cerebral specimens were immunohistochemically analyzed. We were able to show that in patients with acute ischemic or hemorrhagic stroke numerous mDC and T cells were located in the infarcted area. Those results are in concordance with the study of Kostulas et al., who described mDC in the rodent infarcted brain [25] . We observed a distribution of mDC, colocalized with T cells, around the cerebral vessels in the stroke area which is a strategic location between the immune system and the CNS. Thus, it seems likely that mDC are initiating an antigenspecific immune response through T cell activation there. HLA-DR expressing cells by far exceeded the number of mDC in the stroke area. HLA-DR expression seemed to be associated with residential cells such as astrocytes. However, it is questionable whether those CNS-resident cells are able to sufficiently induce an immune response comparable to professional antigen-presenting cells. It is possible that the observed expression of HLA-DR on residential cells is only an epiphenomenon induced by invaded immune cells, as described for EAE [26] . An important finding was that patients with older stroke showed persisting mDC and T cells, and high HLA-DR expression in the infarcted area, suggesting a long-lasting immune response after stroke. In concordance, long-term persistence of macrophages was previously shown in the infarcted area after stroke by PK11195-PET [27] .
Recent data suggest that the immune pathomechanisms of ischemic and hemorrhagic stroke are very similar [28] . Our present study confirms this opinion, showing that circulating DCP are reduced in both ischemic and hemorrhagic stroke, and are recruited into the affected brain under both conditions. According to the general clinical observation of higher severity of intracranial hemorrhage, our results show that the reduction in circulating DCP is more pronounced in hemorrhagic than in ischemic stroke.
Several limitations of our study have to be acknowledged. Systemic infections often occur after acute stroke. However, in our study we had to exclude patients with obvious systemic infections, since it is well known that circulating DCP are recruited to the site of infection. Thus, the exclusion of patient with systemic infections was in this case necessary to be able to investigate whether circulating DCP are reduced in acute stroke due to their recruitment into the infarcted brain.
Unexpectedly, no significant changes in the levels of circulating DCP were observed in patients with asymptomatic ACI stenosis compared to controls, although it is known that circulating DCP emigrate into atherosclerotic lesions [13, 21] . In contrast, in patients with stable coronary artery disease a significant decrease in circulating DCP was described which is dependent of the extent of coronary atherosclerotic burden [22] . However, limited number of patients with ACI stenosis in the present study may be the reason that we were unable to detect any alterations.
As described above, the most likely reason for the decrease in circulating DCP in patients after stroke seems to be their recruitment into the infarcted brain. However, other theoretically possible reasons have to be taken into account: (1) reduced production of DCP in the bone marrow or (2) increased apoptosis of circulating DCP. Those other reasons could not be definitely excluded in our present study. To the best of our knowledge, there exists no published data reporting a selective depression of the production of circulating DCP in the bone marrow without any impairment of the production of other blood leukocytes. In the case of lymphocytes, an increased apoptosis was described as reason for their transient reduction after stroke [29] . However, apoptotic cells show a decreased size in flow cytometry. In our analysis, circulating mDCP and pDCP had a very constant size, so that apoptosis seems to be unlikely reason for their decrease in circulation. On the other hand, it is possible that not all myeloid DC which were found in the infarcted brain were recruited from the circulation, but might have developed from local cerebral cells [25] .
In conclusion, we show for the first time a significant transient decrease in circulating DCP in patients with stroke. The reason for this decrease is probably an enhanced recruitment of DCP from blood into the infarcted brain. Less circulating DCP might be leading to immunodepression, resulting in frequent systemic infections and worse outcome in stroke patients. On the other hand, mDC invaded into the brain after stroke may activate T cells against newly-recognized neuroepitopes, inducing a long-lasting immune response, which leads to further neurological damage. Thus, novel strategies based on modulation of DC migration or function might be a promising therapeutic approach to prevent systemic infections or further neurological damage in stroke patients. A c c e p t e d M a n u s c r i p t
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